Go offline with the Player FM app!
Famotidine and Lockdowns - COVID Solutions?
Manage episode 323948745 series 2931422
The world of COVID-19 is always changing. Join Geoff Wall for a rapid fire of updates regarding famotidine, lockdowns, and ivermectin as evaluated for efficacy in COVID-19.
The GameChangers
The use of high-dose famotidine in the treatment of COVID-19 has demonstrated moderate safety, but questionable efficacy. Additionally, a recent meta-analysis examining the efficacy of lockdown on the spread of COVID-19 had several limitations that should be taken into consideration.
Show Segments
00:00 – Introductions
01:56 – Famotidine in the Treatment of COVID-19
10:52 – Effects of Lockdown on COVID-19 Mortality
18:26 – Ivermectin Treatment of COVID-19 in High-Risk Patients
23:45 – Closing Remarks
Host
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Redeem your CPE or CME credit here!
Need a membership?
References and resources:
- References and resources:
1. Oral Famotidine Versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blind, Data-Intense, Phase 2 Clinical Trial
2. A Literature Review and Meta-Analysis of the Effects of Lockdowns on COVID-19 Mortality. Pre-Publication.
3. Efficacy of Ivermectin Treatment on Disease Progression Among Adults with Mild to Moderate COVID-19 and Comorbidities
Continuing Education Information:
Learning Objectives:
- 1. Describe the latest information on masks and other non-pharmacologic interventions to halt the spread of COVID-19
2. Discuss the recent randomized controlled trial evaluating famotidine use in early COVID-19 positive patients
Dr. Wall is a member of the Janssen Speaker's Bureau.
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-142-H01-P
Initial release date: 03/28/22
Expiration date: 03/28/2023
295 episodes
Manage episode 323948745 series 2931422
The world of COVID-19 is always changing. Join Geoff Wall for a rapid fire of updates regarding famotidine, lockdowns, and ivermectin as evaluated for efficacy in COVID-19.
The GameChangers
The use of high-dose famotidine in the treatment of COVID-19 has demonstrated moderate safety, but questionable efficacy. Additionally, a recent meta-analysis examining the efficacy of lockdown on the spread of COVID-19 had several limitations that should be taken into consideration.
Show Segments
00:00 – Introductions
01:56 – Famotidine in the Treatment of COVID-19
10:52 – Effects of Lockdown on COVID-19 Mortality
18:26 – Ivermectin Treatment of COVID-19 in High-Risk Patients
23:45 – Closing Remarks
Host
Geoff Wall, PharmD., BCPS, FCCP, CGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
Redeem your CPE or CME credit here!
Need a membership?
References and resources:
- References and resources:
1. Oral Famotidine Versus Placebo in Non-Hospitalised Patients with COVID-19: A Randomised, Double-Blind, Data-Intense, Phase 2 Clinical Trial
2. A Literature Review and Meta-Analysis of the Effects of Lockdowns on COVID-19 Mortality. Pre-Publication.
3. Efficacy of Ivermectin Treatment on Disease Progression Among Adults with Mild to Moderate COVID-19 and Comorbidities
Continuing Education Information:
Learning Objectives:
- 1. Describe the latest information on masks and other non-pharmacologic interventions to halt the spread of COVID-19
2. Discuss the recent randomized controlled trial evaluating famotidine use in early COVID-19 positive patients
Dr. Wall is a member of the Janssen Speaker's Bureau.
0.05 CEU | 0.5 Hrs
ACPE UAN: 0107-0000-22-142-H01-P
Initial release date: 03/28/22
Expiration date: 03/28/2023
295 episodes
All episodes
×Welcome to Player FM!
Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.